Human/Mouse G9a/EHMT2 Antibody

Detection of Mouse G9a/EHMT2 by Western Blot

G9a is not required for the transcriptional repression of selected early embryonic genes during retinoic acid (RA)-induced differentiation. The indicated mESC lines were untreated (0) or treated with 1 μM RA for 2, 4 or 8 days. (A) Immunoblots were used to determine G9a, Oct3/4 and GAPDH (loading control) protein levels in whole cell extracts. (B) Graph shows the messenger (mRNA) levels for the indicated genes using RT-qPCR analysis with Ubiquitin C (UBC) as the normalization control. All mRNA levels are normalized to the TT2 0 RA sample. Results shown are mean ± SD for three PCR reactions performed on the same cDNA sample and are representative of three independent experiments. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/25478012), licensed under a CC-BY license. Not internally tested by R&D Systems.

Detection of Human G9a/EHMT2 by Immunohistochemistry

G9a expression is positively correlated with cell proliferation and poor prognosis in HNSCC patients. (A) Correlation between Ki-67 and G9a expression. The expression of two proteins were analyzed by IHC staining of tissue microarray (TMA) containing 46 normal and 108 tumor sections from HNSCC patients. The expression level of both Ki-67 and G9a was measured by relative staining intensity multiplied by percentage. Scale bar, 50 μm. (*, p < 0.05; ***, p < 0.001). (B) Ki-67 and G9a IHC staining of serial section of tumors. Low or high Ki-67 and G9a expression were defined by a threshold of 80 and 143, which is the average of relative staining intensity multiplied by percentage of Ki-67 and G9a. Scale bar, 50 μm. (***, p < 0.001). (C) Kaplan-Meier plot of overall survival of 77 HNSCC patients from a National Taiwan University Hospital cohort stratified by G9a expression level. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/25027955), licensed under a CC-BY license. Not internally tested by R&D Systems.

Detection of Human G9a/EHMT2 by Immunohistochemistry

G9a expression is positively correlated with cell proliferation and poor prognosis in HNSCC patients. (A) Correlation between Ki-67 and G9a expression. The expression of two proteins were analyzed by IHC staining of tissue microarray (TMA) containing 46 normal and 108 tumor sections from HNSCC patients. The expression level of both Ki-67 and G9a was measured by relative staining intensity multiplied by percentage. Scale bar, 50 μm. (*, p < 0.05; ***, p < 0.001). (B) Ki-67 and G9a IHC staining of serial section of tumors. Low or high Ki-67 and G9a expression were defined by a threshold of 80 and 143, which is the average of relative staining intensity multiplied by percentage of Ki-67 and G9a. Scale bar, 50 μm. (***, p < 0.001). (C) Kaplan-Meier plot of overall survival of 77 HNSCC patients from a National Taiwan University Hospital cohort stratified by G9a expression level. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/25027955), licensed under a CC-BY license. Not internally tested by R&D Systems.